- Profile
- prev
- next
General
-
Headquarters
New York, 10014, United States
-
Founders & Team
Adam Ashwal
-
Year Founded
2020
-
Number of employees
10
-
Company type
Private company
-
Funding stage
Pre-seed
Technical Details
-
Product modality
drug discovery
About
We're building a new type of biocomputer that bridges nature and silicon, calculating better solutions to death and disease.
Fully automated, massively parallelized, we’re running in vivo studies with speed, rigor, and scale. A Pareto-efficient search of drug candidates and truly meaningful validation — all-too-absent in status-quo pharmacology — will slash cost, time-to-market, and time-to-patient.